Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Proliferative Breast Disease”

38 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 38 results

Not applicableStudy completedNCT00612560
What this trial is testing

Flaxseed, Aromatase Inhibitors and Breast Tumor Characteristics

Who this might be right for
Breast Cancer
Roswell Park Cancer Institute 28
Not applicableStudy completedNCT03860740
What this trial is testing

Effect of Physical Exercise on Tumor Proliferation of Luminal B Breast Cancer Patients

Who this might be right for
Breast CancerLuminal B
Spanish Breast Cancer Research Group 12
Early research (Phase 1)Study completedNCT00968656
What this trial is testing

Assessment of Cellular Proliferation in Tumors by Positron Emission Tomography (PET) Using [18F]ISO-1

Who this might be right for
Breast CancerHead and Neck CancerDiffuse Large B-cell Lymphoma
Washington University School of Medicine 31
Testing effectiveness (Phase 2)WithdrawnNCT01814865
What this trial is testing

Anti-Proliferative Effects and Genomic Alterations of Abiraterone Acetate Compared to an Aromatase Inhibitor in Post-menopausal HR+ Operable Breast Cancer

Who this might be right for
Post-menopausal ER+ Stage I-IIIA Primary Operable Breast Cancer
British Columbia Cancer Agency
Early research (Phase 1)Ended earlyNCT02936206
What this trial is testing

Examination of Breast Cancer Cells of Pre-menopausal and Post-menopausal Women Before and After Exposure to Tamoxifen or Fulvestrant.

Who this might be right for
Breast Cancer
Icahn School of Medicine at Mount Sinai 2
Testing effectiveness (Phase 2)Study completedNCT00930579
What this trial is testing

Pre-Surgical Study: Effect of Metformin on Breast Cancer Proliferation

Who this might be right for
Breast Cancer
Columbia University 35
Testing effectiveness (Phase 2)Study completedNCT01367288
What this trial is testing

Comparative Study of Neoadjuvant Chemotherapy With and Without Zometa for Management of Locally Advanced Breast Cancers

Who this might be right for
Locally Advanced Breast CancerDuctal Histologic TypeWithout Her 2 Overexpression
Hospices Civils de Lyon 53
Not applicableStudy completedNCT01016665
What this trial is testing

Anastrozole Reduced Proliferation and Progesterone Receptor Indexes in Short Term Hormone Therapy

Who this might be right for
Breast Cancer
Federal University of São Paulo 71
Testing effectiveness (Phase 2)Study completedNCT03454529
What this trial is testing

The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast Cancer

Who this might be right for
Invasive Breast CarcinomaStage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7+4 more
Michael Simon 24
Testing effectiveness (Phase 2)Study completedNCT01500577
What this trial is testing

A Prevention Trial in Subjects at High Risk for Breast Cancer

Who this might be right for
Breast Cancer
European Institute of Oncology 150
Not applicableStudy completedNCT00259597
What this trial is testing

Nuclear Morphology of Breast Cells in Ductal Lavage

Who this might be right for
Benign Breast Disease
University of Michigan 57
Not applicableStudy completedNCT01273415
What this trial is testing

Usefulness of Ki67 Index in Hormone Receptor-positive Breast Cancer

Who this might be right for
Breast Cancer
Samsung Medical Center 1,070
Very early researchStudy completedNCT03954015
What this trial is testing

Comparison of Three Methods for Early Detection of Breast Cancer

Who this might be right for
Proliferative Breast Disease
Mayo Clinic 3
Not applicableEnded earlyNCT02095184
What this trial is testing

GCC 1366: Anti-Proliferative Response to NeoAdjuvant AIs in Overweight and Obese Patients

Who this might be right for
Breast Cancer
University of Maryland, Baltimore 42
Testing effectiveness (Phase 2)Study completedNCT01605396
What this trial is testing

A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064)

Who this might be right for
Breast Neoplasms
Merck Sharp & Dohme LLC 80
Very early researchStudy completedNCT03197389
What this trial is testing

Effect of Pembrolizumab (Keytruda®) on Biomarkers in Early Breast Cancer.

Who this might be right for
Breast CancerTriple Negative Breast CancerHormone Receptor Negative Neoplasm
Universitaire Ziekenhuizen KU Leuven 54
Testing effectiveness (Phase 2)Study completedNCT00982319
What this trial is testing

Study to Evaluate the Effect of Sulforaphane in Broccoli Sprout Extract on Breast Tissue

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 34
Early research (Phase 1)Looking for participantsNCT06307249
What this trial is testing

Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA

Who this might be right for
CancerSolid TumorColorectal Cancer+7 more
Lebanese University 50
Not applicableStudy completedNCT03886389
What this trial is testing

Breast Cancer Diet Intervention Study

Who this might be right for
Early-stage Breast CancerCarbohydrate EngorgementProliferation+2 more
Helse Stavanger HF 80
Very early researchStudy completedNCT02802748
What this trial is testing

Phase 0 Study of Metronomic Oral Vinorelbine and Letrozole in HR+/HER2-negative Early Breast Cancer Patients (VENTANA)

Who this might be right for
Breast Cancer
SOLTI Breast Cancer Research Group 60
Load More Results